Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial

Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial

Background. During the past 20 years, some large international studies have been conducted that evaluated the effectiveness of treatment programs for children with medulloblastoma. At the same time, in the standard risk group, fairly high rates of 5-year overall survival (OS) and event-free survival...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andrei S. Levashov, Svetlana R. Zagidullina, Anna M. Stroganova, Dmitrii A. Khochenkov, Marina V. Ryzhova, Sergei K. Gorelyshev, Shavkat U. Kadirov, Stepan S. Babelyan, Vasilii A. Grigorenko, Dmitrii A. Sidel’nikov, Natalia N. Subbotina, Vidmante V. Daylidite, Georgii L. Mentkevich
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2020
Materias:
children
medulloblastoma
standard and high risk group
craniospinal radiation
high-dose chemotherapy
molecular biological factors
prognosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/a12eb34ca0b74cc593911e1f8ebacdcb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a12eb34ca0b74cc593911e1f8ebacdcb

Ejemplares similares